LENZ Therapeutics, Inc. (LENZ) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -33.58M | -33.02M | -8.59M | -11.51M | -16.05M | -9.08M | -10.58M | -15.79M | -23.94M | -20.97M | -13.09M | -5.25M | -12.8M | -7.46M | -22.22M | -22.09M | -21.24M | -15.59M | -15.41M | -13.78M |
| Operating CF Margin % | -1766.54% | -2079.66% | -68.7% | -230.16% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -109.25% | -263.79% | 18.84% | 27.14% | 32.95% | 56.71% | 19.16% | -200.97% | -87.04% | -180.99% | 41.09% | 76.25% | 39.75% | 52.14% | -44.13% | -60.29% | -163.52% | -195.83% | - | - |
| Net Income | -41.49M | -35.9M | -16.7M | -14.91M | -14.62M | -12.65M | -10.21M | -10.25M | -16.65M | -23.69M | -18.88M | -14.73M | -12.67M | -9.43M | -24.68M | -26.66M | -26.14M | -18.93M | -14.59M | -17.53M |
| Depreciation & Amortization | 111K | -3.3M | 125K | 19K | 36K | 25K | 10K | 18K | 5K | 4K | 4K | 4K | 3K | 3K | 2.17M | 2.06M | 1.89M | 0 | 556K | 100K |
| Stock-Based Compensation | 0 | 3.68M | 3.47M | 2.85M | 2.56M | 1.63M | 2.19M | 1.6M | 947K | 518K | 494K | 0 | 142K | 377K | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 4.42M | 3M | -779K | -888K | -1.05M | -1.41M | -1.36M | -959K | 772K | -780K | -421K | 7.7M | 16K | -5K | 2.65M | 4.12M | 3.7M | 3.88M | 2.37M | 2.03M |
| Working Capital Changes | 3.38M | -503K | 5.3M | 1.43M | -2.97M | 3.33M | -1.21M | -6.2M | -9.01M | 2.98M | 5.71M | 1.78M | -289K | 1.59M | -2.35M | -1.62M | -684K | -543K | -3.75M | 1.61M |
| Change in Receivables | -14K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -889K | -3.33M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 6.76M | -156K | 1.69M | -857K | -771K | 1.32M | -1.64M | -2.69M | -1.27M | 1.09M | 1.97M | -1.61M | -567K | 3.61M | 392K | 301K | 582K | 710K | -2.34M | 3.37M |
| Cash from Investing | 33.16M | -89.81M | -4.33M | -414K | 18.89M | -11.86M | -62.23M | -98.39M | 18M | 15.17M | -17.91M | -70.04M | -6K | -3K | 3.5M | -88.22M | -170.67M | -981K | -3.64M | -763K |
| Capital Expenditures | -18K | -38K | -439K | -240K | -110K | -149K | -186K | -133K | 0 | 0 | 0 | 353K | -6K | -3K | -915K | -1.39M | -3.27M | -981K | -3.64M | -763K |
| CapEx % of Revenue | 0.95% | 2.39% | 3.51% | 4.8% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -111.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 14K | 122.61M | 598K | 26.49M | 44K | 53K | 29.82M | -2.14M | 171.27M | -1.91M | -568K | 83.19M | 83.18M | 20.25M | -59K | 412K | 0 | 313K | 31.89M | 219.5M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 14K | 122.61M | 598K | 26.07M | 44K | -85K | 29.83M | -3.56M | 53.39M | 0 | 0 | 83.19M | 82.98M | 20.24M | -59K | 412K | 0 | 7K | 31.89M | 219.5M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8K | 0 | 0 | -79K | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 421K | 0 | 138K | -13K | 1.43M | 117.88M | -1.91M | -568K | 0 | 203K | 15K | 0 | 0 | 0 | 306K | 0 | 0 |
| Net Change in Cash | -407K | -220K | -12.32M | 14.57M | 2.88M | -20.89M | -42.99M | -116.32M | 165.33M | -7.71M | -31.57M | 58.7M | 70.38M | 12.79M | -18.78M | -109.9M | -191.91M | -17.98M | 12.84M | 204.95M |
| Free Cash Flow | -33.6M | -33.06M | -9.03M | -11.75M | -16.16M | -9.23M | -10.77M | -15.93M | -23.94M | -20.97M | -13.09M | -4.89M | -12.8M | -7.47M | -23.13M | -23.48M | -24.51M | -16.57M | -19.05M | -14.55M |
| FCF Margin % | -1767.49% | -2082.05% | -72.22% | -234.96% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -107.93% | -258.33% | 16.16% | 26.24% | 32.49% | 56% | 17.73% | -225.39% | -86.95% | -180.87% | 43.42% | 79.15% | 47.77% | 54.95% | -21.42% | -61.4% | -191.13% | -181.73% | - | - |
| FCF per Share | -1.07 | -1.06 | -0.32 | -0.42 | -0.59 | -0.34 | -0.40 | -0.62 | -5.07 | -2.53 | -1.60 | -0.60 | -1.60 | -0.94 | -2.93 | -3.01 | -3.18 | -2.00 | -2.30 | -1.82 |
| FCF Conversion (FCF/Net Income) | 0.81x | 0.92x | 0.51x | 0.77x | 1.10x | 0.72x | 1.04x | 1.54x | 1.44x | 0.89x | 0.69x | 0.36x | 1.01x | 0.79x | 0.90x | 0.83x | 0.81x | 0.82x | 1.06x | 0.79x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |